Once the SignalPath acquisition closes, Verily will combine the company with Baseline, a cornerstone of its clinical trials work. Baseline to date has focused on developing virtual and digital services for clinical research, while SignalPath adds a network of customer research sites and site-based tools.
from Section Page News - Modern Healthcare https://ift.tt/3kbZU7o
